- GFBiochemicals started commercial production at a 10,000 MT/a levulinic acid plant in Caserta, Italy.
- The announcement was made at the BIO World Congress on Industrial Biotechnology in Montreal.
- Caserta is now the world's largest operational production plant for levulinic acid.
- The company achieved this milestone on schedule.
Production Launch
GFBiochemicals has commenced commercial production at its 10,000 MT/a capacity levulinic acid plant located in Caserta, Italy. This significant development was announced at the BIO World Congress on Industrial Biotechnology in Montreal.
Industry Milestone
With this launch, Caserta becomes the world's largest operational production plant for levulinic acid. GFBiochemicals is the first company to produce levulinic acid at a commercial scale directly from biomass, marking a notable achievement in the industry.
Technological Advancements
Chief Commercial Officer Marcel van Berkel highlighted that the unique technology employed at the Caserta plant allows for a fundamentally lower price range. This advancement opens up access to previously untapped market segments, broadening the potential applications of levulinic acid.
Team Effort
CEO Maxim Katinov praised the engineering and R&D teams for their efforts in achieving this milestone on schedule. The successful start-up of commercial-scale production underscores the company's capability to deliver results as planned.
